|
|
Progress in Prevention of IFIs & Promise of New Diagnostic Techniques
|
Release Date: July 9, 2009
Credit Expiration Date: July 9, 2010
|
Credit Hours
Physician CME: 1.0
Pharmacist CPE: 1.0 (0.10 CEUs)
|
|
Activity Type
Knowledge-based and competence-based
|
Educational Overview
When it comes to the management of invasive fungal infections (IFIs), a great deal of progress has been made
with significant advancements in prevention, diagnosis, and treatment. Promising new clinical data allow for more
targeted antifungal prophylaxis, identifying at-risk patients who would benefit most from this strategy. Evolving
radiographic and serologic diagnostic techniques enable clinicians to initiate therapy at the time when therapeutic
intervention is most effective. More options when determining treatment lead to better health outcomes for
more patients at risk of or who have IFIs.
Today’s healthcare teams are more vigilant in anticipating the possibility of a fungal infection. As a
result, survival rates continue to increase while health outcomes improve. These positive efforts must
continue. Clinicians, who acquire a level of knowledge and familiarity with new prevention
approaches, diagnostic techniques, and management strategies for IFIs, will be empowered to
make timely, accurate, evidence-based decisions that benefit their patients.
|
Target Audience
This activity has been developed for clinical pharmacists, infectious diseases physicians, hematologists/oncologists, and
transplant physicians responsible for the management of IFIs.
|
Purpose Statement
The purpose of this activity is to educate physicians and pharmacists involved in the management
of patients at risk of invasive fungal infections (IFIs) on prevention through the appropriate
use of antifungal prophylaxis and early detection using new diagnostic techniques. With this
knowledge, healthcare professionals will be able to minimize the incidence of IFIs and diagnose
infection during the early stages.
|
Learning Objectives
At the conclusion of this activity, learners should be able to
- Assess the appropriate use of antifungal prophylaxis in immunocompromised patients
- Evaluate the utility of the latest diagnostic techniques for early detection of IFIs
|
Faculty
Pranatharthi H. Chandrasekar, MD
Professor of Medicine
Wayne State University School of Medicine
Detroit, MI
Richard H. Drew, PharmD, MS, BCPS
Professor, Campbell University School of Pharmacy
Associate Professor of Medicine (Infectious Diseases)
Duke University School of Medicine
Durham, NC
|
Accreditation
Physicians
Accreditation Statement: This activity has been planned and implemented in accordance with the Essential
Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint
sponsorship of Center for Independent Healthcare Education (Center) and Vemco MedEd. Center is accredited
by the ACCME to provide continuing medical education for physicians.
Credit Designation: Center designates for this activity a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians
should only claim credit commensurate with the extent of their participation in the activity.
Pharmacists
Accreditation Statement: Center for Independent Healthcare Education (Center) is accredited by the
Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Credit Designation: Center has assigned 1.0 contact hour (0.1 CEUs) of continuing pharmacy education
credit for participation in this activity.
ACPE Universal Activity Number: 473-999-09-012-H012-P
Estimated time to complete activity: 1 hour
|
Method of Participation and Instruction for Credit
- Review the entire CME/CE information including target audience, learning objectives, and disclosures.
- Review this activity in its entirety.
- Complete the Post Test, Evaluation, and Credit Application form.
- Mail the completed Post Test, Evaluation, and Credit Application form to Vemco MedEd, 245 US Highway 22, Suite 304, Bridgewater, NJ 08807 Or Fax to (908) 450-3300.
Documentation of credit will be mailed within 4 weeks of receipt of the completed Post Test, Evaluation, and Credit Application form.
|
Disclosure of Conflicts of Interest
Center for Independent Healthcare Education requires faculty, planners, and others who are in a position
to control the content of continuing education activities to disclose to the audience any real or apparent
conflict of interest related to the activity. All identified conflicts of interest are reviewed to ensure
fair balance, objectivity, and scientific rigor in all activities. The faculty is further required to
disclose discussion of off-label uses in their presentations.
|
Disclosure
Faculty
Pranatharthi H. Chandrasekar, MD
Research/Grant Support: Pfizer
Advisory Boards: Basilea and Pfizer
Speakers Bureaus: Schering-Plough, Astellas, Merck, Pfizer, and Enzon
Richard H. Drew, PharmD, MS, BCPS
Consultant: Merck, Theravance, Schering-Plough, Forest, Wyeth-Ayerst, and Ortho-McNeil
Research Support: Schering-Plough, NeuTec, and Cubist
Speaker Honoraria: Schering-Plough, Ortho-McNeil, Enzon, and Astellas
Development Team: CustomID
Planning Committee Members
Employees of Center for Independent Healthcare Education and Vemco MedEd have no relevant financial relationships to disclose.
Off-label Disclosure Statement
During this activity, the following off-label uses of antifungal agents are discussed: itraconazole
(for antifungal prophylaxis), voriconazole (for antifungal prophylaxis), liposomal amphotericin
B (for antifungal prophylaxis), and inhalational formulations of amphotericin B (for antifungal prophylaxis).
|
Joint Sponsorship
This activity is jointly sponsored by Center for Independent Healthcare Education and Vemco MedEd.
|
Commercial Support
This activity is supported by an educational grant from Schering-Plough Corporation.
|
Acknowledgement
The authors wish to thank Marco P. Cicero, PhD, of Vemco MedEd, LLC for medical writing and editorial assistance.
|
Fee
There is no fee associated with this activity.
|
Hardware/Software Requirements
Web Browser
Internet Explorer or Mozilla
Note: Please disable any “pop-up blocker” features.
Software
Adobe Acrobat Reader version 4 or above to view PDF files (If you do not have Acrobat Reader, you can download it
for free from http://get.adobe.com/reader)
Connection Speed
Cable, DSL, or better of at least 300 kbps
Hardware
PC or Apple
System Check
Please e-mail any questions or concerns to info@vemcomeded.com.
|
Copyright Statement
Copyright © 2009 Vemco MedEd, LLC. All Rights Reserved.
Permission for accreditation use granted to Center for Independent Healthcare Education.
|
Disclaimer
The opinions expressed in this educational activity are those of the faculty and do not reflect the views of
Center for Independent Healthcare Education (Center) and Vemco MedEd. This educational activity may discuss
off-label and/or investigational uses and dosages for therapeutic products/procedures that have not been
approved by the United States Food and Drug Administration (FDA). Center and Vemco MedEd do not recommend the
use of any product/procedure outside of the labeled indications. A qualified healthcare professional should be
consulted before using any therapeutic product/procedure discussed. Clinicians should verify all information and
data before treating patients or employing any therapies described in this continuing education activity. Please
refer to the prescribing information for each product/procedure for approved
indication, contraindications, and warnings.
|
Privacy Policy
http://www.vemcomeded.com/privacy.asp
|
Contact Information
For questions regarding the accreditation of this activity, please contact Center for Independent Healthcare
Education at info@jointsponsor.com
|
Start Activity
|
|
|
|
|